The suit alleges that Berkeley, which is currently running a national ad campaign featuring innuendos and a silent 'Smiling Bob' character, claimed that Enzyte would add one to three inches to a man's penis size or customers would get double their money back, among other similar claims.
In a recent interview, Berkeley founder and CEO Steven Warshak admitted that the company withdrew its claims that Enzyte added inches to a man's penis because no third-party independent trials were conducted to substantiate the claim.
Berkeley has since pulled claims about Enzyte increasing penis size from its Web site and marketing materials, and replaced them with disclaimers that "Enzyte will not alter the shape or size of your penis," according to the suit.
Customers trying to collect on Enzyte's guarantee received deceptive attempts to coerce them into giving up their right to receive a refund, and ultimately did not receive twice the purchase amount as promised, according to the complaint.
The suit seeks to represent all those who purchased Enzyte, including those purchasers to whom the company claimed that the supplement increases penis size, except residents of California. Consumers seek class action status, reimbursement for purchases of Enzyte and damages.
Read the press release, the Frequently Asked Questions and the complaint for more information.

| SHARE: |
|
| CONTACT US | CYCLING TEAM | INSTITUTIONAL INVESTORS | FOLLOW US ONLINE: |
|
|

